One in 12 American adults has been diagnosed with a substance use disorder, and there are many more who go undiagnosed. This reality is fueling the need for more individualized and diversified addiction care, including true dialectical behavior therapy (DBT) and medication assisted treatment (MAT), in order to increase the likelihood of a successful recovery and ultimately survival. Today, Zach and Michael interview Michelle Dubey about Landmark Recovery’s addiction treatment programs, from inpatient care to using prescription medications in combination with long-term DBT to treat opioid use disorders. They also discuss PTSD versus trauma disorders, measuring success after treatment, and how to determine if medication assisted treatment is right for you. Michelle has served as Chief Clinical Officer of Landmark since 2019, and she has been with the company since its beginnings in 2016. As CCO, Michelle is responsible for development and oversight of Landmark’s clinical programming, as well as quality assurance and compliance. She is a Licensed Clinical Social Worker, a Certified Clinical Trauma Specialist, and brings more than 13 years of experience working with individuals and families healing from substance use and other co-occurring disorders.
[6:45] Opioid replacement therapy (medication assisted treatment).
[8:00] Dialectical behavior therapy versus DBT-informed treatment.
[10:00] An intensive outpatient program is a time to identify, but not unpack, trauma related to substance abuse.
[11:55] DBT isn’t a trauma treatment; it’s intended to develop the skills necessary to manage trauma.
[15:14] Adverse Childhood Experiences (ACEs), and PTSD versus trauma disorders.
[18:08] The significance of having recovery programs that fit anyone who has a need to find recovery, and why abstinence-based programs don’t work for everyone.
[22:23] Measuring success after treatment for a substance use disorder.
[27:00] What is medication assisted treatment, and is it right for you?